SAN DIEGO, CA, Clinical-stage biopharmaceutical company has raised $142 million in Series C.
Poseida Therapeutics Snares $142M in Series C
SAN DIEGO, CA, Clinical-stage biopharmaceutical company has raised $142 million in Series C.
